| scholarly article | Q13442814 |
| P2093 | author name string | B A Huet | |
| U Singh | |||
| I Jialal | |||
| S Devaraj | |||
| P2860 | cites work | Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells | Q44039853 |
| NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older | Q44418730 | ||
| Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. | Q44470244 | ||
| Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy | Q46340617 | ||
| Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. | Q46464366 | ||
| Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction | Q46565224 | ||
| Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension | Q46842377 | ||
| Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation | Q47360467 | ||
| Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes | Q47907647 | ||
| The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. | Q51467833 | ||
| Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes | Q57790499 | ||
| Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy | Q63285824 | ||
| Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures | Q78570627 | ||
| Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk | Q80121226 | ||
| Endothelial progenitor cell dysfunction: mechanisms and therapeutic approaches | Q80627331 | ||
| Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease | Q81554106 | ||
| Circulating endothelial progenitor cells and cardiovascular outcomes | Q28271167 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
| Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia | Q30760797 | ||
| Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors | Q36102374 | ||
| Endothelial progenitor cells and vascular biology in diabetes mellitus: current knowledge and future perspectives. | Q37065482 | ||
| Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. | Q37076991 | ||
| Endothelial progenitor cell number and colony-forming capacity in overweight and obese adults. | Q37098713 | ||
| Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension | Q37100212 | ||
| Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases | Q37206574 | ||
| Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo | Q37327619 | ||
| Mechanisms and significance of progenitor cell reduction in the metabolic syndrome. | Q37381722 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men | Q39513420 | ||
| Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair | Q40417766 | ||
| C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. | Q42460041 | ||
| Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 | ||
| P433 | issue | 1 | |
| P921 | main subject | metabolic syndrome | Q657193 |
| endothelium | Q111140 | ||
| circulatory system | Q11068 | ||
| P304 | page(s) | 297-302 | |
| P577 | publication date | 2010-02-04 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk | |
| P478 | volume | 211 |
| Q38124918 | Activated platelets correlate with mobilization of naïve CD34(+) cells and generation of CD34(+) /KDR(+) cells in the circulation. A meta-regression analysis |
| Q35497928 | Adipose tissue dysregulation in patients with metabolic syndrome |
| Q37780807 | Bone marrow and pancreatic islets: an old story with new perspectives |
| Q36303136 | Bone marrow transplantation improves endothelial function in hypertensive Dahl salt-sensitive rats |
| Q57795698 | Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair |
| Q41813965 | Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity. |
| Q34640128 | Circulating levels of endothelial progenitor cell mobilizing factors in the metabolic syndrome. |
| Q92195203 | Circulating microRNAs and endothelial cell migration rate are associated with metabolic syndrome and fitness level in postmenopausal African American women |
| Q49345031 | Comparative Anti-Platelet Profiling Reveals a Potent Anti-Aggregatory Effect of CD34+ Progenitor Cell-Derived Late-Outgrowth Endothelial Cells in vitro |
| Q48144378 | Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies. |
| Q34168401 | Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease |
| Q35222376 | Dysfunctional endothelial progenitor cells in metabolic syndrome |
| Q41072129 | Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients |
| Q30415670 | Early accelerated senescence of circulating endothelial progenitor cells in premature coronary artery disease patients in a developing country - a case control study. |
| Q27025888 | Effects of Cardiovascular Risk Factors on Endothelial Progenitor Cell |
| Q33825706 | Endothelial angiogenesis is directed by RUNX1T1-regulated VEGFA, BMP4 and TGF-β2 expression |
| Q39121106 | Endothelial progenitor cells: Exploring the pleiotropic effects of statins |
| Q92500962 | Exercise and Cardiovascular Progenitor Cells |
| Q45831019 | Expansion of Umbilical Cord Blood Aldehyde Dehydrogenase Expressing Cells Generates Myeloid Progenitor Cells that Stimulate Limb Revascularization |
| Q37071335 | Glycogen synthase kinase 3β inhibition enhanced proliferation, migration and functional re-endothelialization of endothelial progenitor cells in hypercholesterolemia microenvironment |
| Q36236364 | Impaired Circulating Angiogenic Cells Mobilization and Metalloproteinase-9 Activity after Dynamic Exercise in Early Metabolic Syndrome |
| Q42952026 | Increased osteocalcin-positive endothelial progenitor cells in hypogonadal male patients |
| Q35841261 | Increased toll-like receptor activity in patients with metabolic syndrome |
| Q28385776 | Insulin sensitizers prevent fine particulate matter-induced vascular insulin resistance and changes in endothelial progenitor cell homeostasis |
| Q57805880 | Intrinsic Vascular Repair by Endothelial Progenitor Cells in Acute Coronary Syndromes: an Update Overview |
| Q34714056 | Isolation of human umbilical cord blood aldehyde dehydrogenase-expressing progenitor cells that modulate vascular regenerative functions in vitro and in vivo |
| Q50985903 | Metabolic syndrome is associated with decreased circulating endothelial progenitor cells and increased arterial stiffness in systemic lupus erythematosus. |
| Q42922925 | MicroRNA and mechanisms of impaired angiogenesis in diabetes mellitus |
| Q38734247 | Molecular mechanisms associated with diabetic endothelial-erectile dysfunction |
| Q47881880 | Neovascularization and Synaptic Function Regulation with Memantine and Rosuvastatin in a Rat Model of Chronic Cerebral Hypoperfusion. |
| Q27024799 | PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty |
| Q38161528 | Prehypertension and the cardiometabolic syndrome: pathological and clinical consequences |
| Q35124843 | Reduction of circulating endothelial progenitor cell level is associated with contrast-induced nephropathy in patients undergoing percutaneous coronary and peripheral interventions |
| Q36721202 | Stimulatory Influences of Far Infrared Therapy on the Transcriptome and Genetic Networks of Endothelial Progenitor Cells Receiving High Glucose Treatment |
| Q36572996 | Stromal-derived factor-1[alpha] correlates with circulating endothelial progenitor cells and with acute lesion volume in stroke patients |
| Q46539901 | Thrombospondin-1-Derived Peptide RFYVVMWK Improves the Adhesive Phenotype of CD34+ Cells From Atherosclerotic Patients With Type 2 Diabetes. |
| Q56986948 | VDR expression on circulating endothelial progenitor cells in dialysis patients is modulated by 25(OH)D serum levels and calcitriol therapy |
| Q27015707 | Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome? |
| Q34505828 | Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization |
| Q34072676 | miR-21 normalizes vascular smooth muscle proliferation and improves coronary collateral growth in metabolic syndrome |
| Q93163630 | miR-548aq-3p is a novel target of Far infrared radiation which predicts coronary artery disease endothelial colony forming cell responsiveness |
| Q34250575 | miRNome traits analysis on endothelial lineage cells discloses biomarker potential circulating microRNAs which affect progenitor activities. |
Search more.